MedPath

Homoeopathic Treatment Of Uterine Fibroid Using Epihysterinum

Phase 4
Conditions
Health Condition 1: D259- Leiomyoma of uterus, unspecified
Registration Number
CTRI/2023/05/052233
Lead Sponsor
RBTS GOVT HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Self reported and prediagnosed cases of Uterine Fibroids.

Patients with symptomatology of Uterine Fibroids.

Cases confirmed by USG or Laproscopy.

Uterine fibroid of size less than 12 weeks

Exclusion Criteria

Patients or its guardian unwilling to take part or not giving consent to join the study.

Diagnosed cases of systemic diseases psychiatric illness or other uncontrolled or life threatening illness affecting quality of life or any organ failure.

Substance abuse and or dependence.

Self reported immunecompromised state.

Uterine Fibroid of size more than 12 weeks

Persistent uterine bleeding despite medical therapy

Excessive pain or pressure symptoms

Recurrent pregnancy loss due to fibroid/or Rapidly growing myoma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in their symptomatology. <br/ ><br>Improvement in Aberdeen Menorrhagia Severity Scale(AMSS) score. <br/ ><br>Timepoint: 0-3 MONTHS <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
uterine fibroids Symptom and Quality of life UFSQOLTimepoint: 0-6 MONTHS
© Copyright 2025. All Rights Reserved by MedPath